vTv Therapeutics, which is developing a drug to treat diabetes, saw its stock rise 113% Wednesday after it announced a $51 million infusion from a private sale of stock to well-known health care investors.
Read More
In the summer of 1960, the FDA made a decision that would forever change family planning conversations. Enovid, the first oral contraceptive, was approved for sale. Since then, research has led to the manufacturing of other options like the IUD, NuvaRing and Nexplanon. All of those options are made...
Read More
Upon completion of the two-week free course, students will earn several certifications in biomanufacturing, including an advanced certificate in biopharmaceutical manufacturing.
Read More
North Carolina’s booming biopharmaceutical manufacturing industry will need at least 8,000 new workers by the end of 2026. Will the state be able to provide that workforce? And how so? A new report examines the issues.
Read More
A Greenville pharmaceutical company is poised to manufacture a new plant-based oral contraceptive as soon as June, now that the drug is approved by the U.S. FDA.
Read More
Next week, Bioprocess Development Group (BPD) is hosting a symposium, “BioGrow: Training and Education Across North Carolina,” to get the word out about the training programs that exist for those interested in a career in biopharmaceuticals.
Read More
The CEO of Liquidia Technologies Inc., a clinical stage biopharmacuetical company, was paid $4 million in total compensation in 2018, a large increase from his compensation of $587,000 in 2017.
Read More
Things not looking so up for Durham’s Heat Biologics. The biopharmaceutical company reported lower-than-expected earnings due to higher research and development expenses. Read more here.
Read More
Liquidia Technologies is moving ahead as a public company under new board leadership.
Read More
